fda spravato - Search News

FDA approves Spravato

Nose spray to treat depression? FDA approves first-of-its-kind medicine

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

UPI News on MSN · 5d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Yahoo · 4d

FDA approves Spravato as first stand-along nasal spray to treat drug-resistant depression

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

mic5d

A Nasal Spray For Depression? FDA Gives Its Approval

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first standalone therapy for adults suffering from major depressive disorder ...

Boing Boing on MSN2d

FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA approves Spravato

Trending now

Related topics